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Abstract Dose calculations based on Monte Carlo (MC) often require sophisticated treatment planning stations 
with long processing time, and this could be issue for many cancer centers. Hence, most of the commercial treatment 
planning system include faster dose calculation engines for the daily clinical routine. Due to advancement in 
technology and computing power, it is now possible to implement MC based dose calculation algorithms in the 
clinical environment. This report summarizes the major findings of various researchers who have investigated 
Acuros XB algorithm, which is the MC based dose calculation algorithm commercially available for dose 
calculations in radiotherapy.   
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Article 
It is evident that accuracy of dose calculations in 
radiotherapy is crucial to prevent mistreatment of patients 
undergoing radiotherapy. The estimation of dose 
deposited in matter is a complex process which involves 
the interaction of radiation beam with the matter. [1] In 
radiation therapy, there are various vendors, which supply 
treatment planning system (TP), and different TPS are 
more likely to have different dose calculation engines. 
This is mainly due to the difference in the radiation beam 
modeling approach among different TPS. Hence, it is 
expected that the dose calculations of one TPS may not be 
similar to that of another TPS. This could create confusion 
for the clinicians if they have to choose one TPS over the 
another.  
In radiation therapy, Monte Carlo (MC) is considered as 
gold standard for dose calculations in radiotherapy. [1] 
MC dose calculations often require sophisticated 
computing services with long processing time and this 
may be an issue for the busy cancer centers. Hence, 
majority of the treatment planning system include faster 
dose calculation engines for the daily clinical routine. Due 
to advancement in technology and computing power, it is 
now possible to implement MC based dose calculation 
algorithms in the clinical environment. This report 
summarizes the major clinical findings of various 
researchers who have investigated Acuros XB algorithm, 
which is the MC-based dose calculation algorithm 
commercially available for dose calculations in 
radiotherapy.  Google Scholar and PubMed were used to 
conduct the literature search of this article. Literature 
search was carried out using terms "Acuros XB" and 
"Dose Calculation". Several researchers [2-7] have 
investigated the accuracy of one of the most recent dose 
calculation engines called Acuros XB, which is considered 
to be MC based engine. As many centers continue to 
explore the accuracy of Acuros XB, current literature 
shows the promising results of Acuros XB as it is 
validated against the measurements and MC simulations. 
[2-7] The accuracy of Acuros XB was reported to be 
within 5% [2] when compared to the MC calculations. 
Other research groups also reported better results, with 
accuracy up to 4.4% [3], 3% [4], 2% [5], and 2.8% [6]. It 
was also reported that Acuros XB calculated results 
showed relatively high level of agreement in 3D gamma 
analysis and dose volume histogram (DVH) comparison 
when compared to the MC simulation results. [7] These 
results suggest high level accuracy of Acuros XB for dose 
calculations in simple and complex situations.   
The literature review suggests that a good number of 
studies have also investigated the clinical use of Acuros 
XB. Kroon et al. [8] evaluated the Acuros XB for lung 
cancer patients and found that Acuros XB calculations 
lower near-minimum PTV dose and mean PTV dose than 
the plans calculated by analytical anisotropic algorithm 
(AAA). Similar finding was reported by Kathirvel et al. [9] 
with Acuros XB producing slightly lower mean PTV dose 
against AAA for lung cancer. Liu and colleagues [10] 
reported lower plan conformation number and higher 
target dose heterogeneity in the Acuros XB plans than in 
the AAA plans. Fogliata et al. [11] reported that the AXB 
predicted lower mean PTV dose in the soft tissue when 
compared to the AAA for both the 6 MV and 15 MV 
photon beams. While the target doses from Acuros XB are 
more favorable than AAA, clinicians must pay special 
attention to the reduced PTV coverage from Acuros XB 
calculations in the case of lung cancer as demonstrated by 
Rana and colleagues. [6, 12, 13] Difference in dose 
calculations can be dependent on the materials assignment 
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in the Acuros XB and the uncertainty in the CT calibration 
curve. Difference in dosimetric results of various 
algorithms may also influence the treatment outcomes of 
the patients undergoing radiotherapy.  Report shows that 
5% to 10% lower dose differences may result in 10% to 
20% changes in tumor control probability (TCP) or 20% 
to 30% changes in normal tissue complication probability 
(NTCP).[7, 14] Hence, it is imperative to perform dose 
calculations in treatment plans using most accurate dose 
calculation algorithms. Furthermore, most of the clinical 
studies on the dose calculation algorithms are done based 
on DVH results. Treatment plan optimizations are also 
done using DVH parameters. It is possible to achieve 
more accurate prediction of TCP and NTCP if treatment 
plans are evaluated using radiobiological parameters. [14] 
In summary, the literature review indicates encouraging 
results from the Acuros XB. This could be used as an 
alternative dose calculation engine for calculations in 
photon radiotherapy.  
References 
[1] Lu L. Dose calculation algorithms in external beam photon 
radiation therapy. Int J Cancer Ther Oncol 2013; 1(2):01025.  
[2] Bush K, Gagne IM, Zavgorodni S, Ansbacher W, Beckham W. 
Dosimetric validation of Acuros XB with Monte Carlo methods 
for photon dose calculations. Med Phys 2011; 38:2208-2221. [3]
Han T, Followill D, Mikell J, Repchak R, Molineu A, Howell R, 
Salehpour M, Mourtada F. Dosimetric impact of Acuros XB 
deterministic radiation transport algorithm for heterogeneous dose 
calculation in lung cancer. Med Phys. 2013; 40(5):051710.  
[4] Kan MW, Leung LH, So RW, Yu PK. Experimental verification 
of the Acuros XB and AAA dose calculation adjacent to 
heterogeneous media for IMRT and RapidArc of nasopharygeal 
carcinoma. Med Phys. 2013 Mar; 40 (3): 031714.  
[5] Stathakis S, Esquivel C, Quino L, Myers P, Calvo O, Mavroidis P, 
Gutiérrez A and Papanikolaou P. Accuracy of the Small Field 
Dosimetry Using the Acuros XB Dose Calculation Algorithm 
within and beyond Heterogeneous Media for 6 MV Photon Beams. 
Int Jour of Med Phys Clin Eng Radiat Onc 2012; 1 (3): 78-87. 
[6] Rana S, Rogers K, Pokharel S, Cheng C. Evaluation of Acuros XB 
algorithm based on RTOG 0813 dosimetric criteria for SBRT lung 
treatment with RapidArc. J Appl Clin Med Phys 2014; 
15:4474.
[7] Ojala JJ, Kapanen MK, Hyödynmaa SJ, Wigren TK, Pitkänen MA. 
Performance of dose calculation algorithms from three generations 
in lung SBRT: comparison with full Monte Carlo-based dose 
distributions. J Appl Clin Med Phys. 2014; 15(2):4662. 
[8] Kroon PS, Hol S, Essers M. Dosimetric accuracy and clinical 
quality of Acuros XB and AAA dose calculation algorithm for 
stereotactic and conventional lung volumetric modulated arc 
therapy plans. Radiat Oncol. 2013; 8(1):149.  
[9] Kathirvel M, Subramanian S, Clivio A, et al. Critical appraisal of 
the accuracy of Acuros-XB and Anisotropic Analytical Algorithm 
compared to measurement and calculations with the compass 
system in the delivery of RapidArc clinical plans. Radiat Oncol 
2013; 8:140.  
[10] Liu HW, Nugent Z, Clayton R, Dunscombe P, Lau H, Khan R. 
Clinical impact of using the deterministic patient dose calculation 
algorithm Acuros XB for lung stereotactic body radiation therapy. 
Acta Oncol. 2013 Aug 19. [Epub ahead of print]  
[11] Fogliata A, Nicolini G, Clivio A, Vanetti E, Cozzi L. Critical 
appraisal of Acuros XB and Anisotropic Analytic Algorithm dose 
calculation in advanced non-small-cell lung cancer treatments. Int 
J Radiat Oncol Biol Phys. 2012; 83(5):1587-95.  
[12] Rana S. Clinical dosimetric impact of Acuros XB and analytical 
anisotropic algorithm (AAA) on real lung cancer treatment plans: 
review. Int J Cancer Ther Oncol 2014; 2(1):02019.  
[13] Ojala J. The accuracy of the Acuros XB algorithm in external 
beam radiotherapy – a comprehensive review. Int J Cancer Ther 
Oncol 2014; 2(4):020417. 
[14] Chetty IJ, Curran B, Cygler JE, et al. Report of the AAPM Task 
Group 105: Issues associated with clinical implementation of 
Monte Carlo-based photon and electron external beam treatment 
planning. Med Phys. 2007; 34(12):4818–53. 
